Cover Image

Evaluating hybrid controls methodology in early-phase oncology trials: a simulation study based on the MORPHEUS-UC trial

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Wang, Guanbo, Costello, Melanie Poulin, Pang, Herbert, Zhu, Jiawen, Helms, Hans-Joachim, Reyes-Rivera, Irmarie, Platt, Robert W., Pang, Menglan, Koukounari, Artemis
Format:	Preprint
Published:	2022
Subjects:	Methodology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Non-collapsibility and Built-in Selection Bias of Hazard Ratio in Randomized Controlled Trials
by: Bian, Helen, et al.
Published: (2024)

Caring for caregivers in early‐phase clinical oncology trials
by: Leah L. Thompson, et al.
Published: (2025)

Investigational Use of Real‐World Data as a Hybrid Control in Pancreatic Ductal Adenocarcinoma From the Randomized Phase Ib/II MORPHEUS Trial
by: Andrew H. Ko, et al.
Published: (2024)

U-DESPE: a Bayesian Utility-based methodology for dosing regimen optimization in early-phase oncology trials based on Dose-Exposure, Safety, Pharmacodynamics, Efficacy
by: Andrillon, Anaïs, et al.
Published: (2025)

Absolute neutrophil count clinical trial eligibility criteria for pediatric oncology phase I and phase I/II trials by sponsorship
by: Jenny Ruiz, et al.
Published: (2024)

A methodology for simulation of hybrid Single-electron/MOS transistor circuits
by: A. Sarmiento-Reyes
Published: (2013)

Early‐phase clinical trials in oncology for adults in France: A preliminary empirical bioethics study
by: Henri‐Corto Stoeklé, et al.
Published: (2024)

Using Principal Progression Rate to Quantify and Compare Disease Progression in Comparative Studies
by: Shen, Changyu, et al.
Published: (2024)

Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials
by: Alexander D. Sherry, et al.
Published: (2024)

Robust integration of external control data in randomized trials
by: Karlsson, Rickard, et al.
Published: (2024)

Toward Generalist Anomaly Detection via In-context Residual Learning with Few-shot Sample Prompts
by: Zhu, Jiawen, et al.
Published: (2024)

Reflections on the opportunities and challenges of applying experience‐based co‐design (EBCD) to phase 1 clinical trials in oncology
by: Nils Graber, et al.
Published: (2024)

Trends in phase 1 oncology clinical trials across Australia; Analysis of ClinicalTrials.gov 2012–2022
by: Nadia Hitchen, et al.
Published: (2024)

A single‐centre study evaluating a geriatric screening tool in oncology phase I trial patients
by: Mary Van Zyl, et al.
Published: (2024)

Advancing randomized controlled trial methodologies: The place of innovative trial design in eating disorders research
by: Elizabeth G. Ryan, et al.
Published: (2024)

Integrating tumor burden with survival outcome for treatment effect evaluation in oncology trials
by: Bhandari, Saurabh, et al.
Published: (2025)

Cancer in rural America: Improving access to clinical trials and quality of oncologic care
by: Joseph M. Unger, et al.
Published: (2025)

Telephone intervention for anxiety management in oncology patients: a randomized clinical trial
by: Bruna Stamm
Published: (2018)

Medication adherence during the run‐in phase of clinical trials: A systematic review of methodological and reporting rigour
by: Non Davies, et al.
Published: (2025)

The role of randomization inference in unraveling individual treatment effects in early phase vaccine trials
by: Chen, Zhe, et al.
Published: (2023)

Actigraphy methodology in the Kids Mod PAH trial: Physical activity as a functional endpoint in pediatric clinical trials
by: Catherine M. Avitabile, et al.
Published: (2024)

MORPHEUS: A Multidimensional Framework for Modeling, Measuring, and Mitigating Human Factors in Cybersecurity
by: Desolda, Giuseppe, et al.
Published: (2025)

One-sample survival tests in the presence of non-proportional hazards in oncology clinical trials
by: Szurewsky, Chloé, et al.
Published: (2025)

The utility of artificial intelligence in gastrointestinal oncology: A systematic review of randomized controlled trials
by: Luke E. Sorensen, et al.
Published: (2025)

High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond
by: Anders Edsjö, et al.
Published: (2024)

Comment on: Incorporation of patient‐reported outcomes in early‐phase clinical trials for childhood and adolescent cancer
by: Gabriel Revon‐Riviere, et al.
Published: (2024)

InCTRLv2: Generalist Residual Models for Few-Shot Anomaly Detection and Segmentation
by: Zhu, Jiawen, et al.
Published: (2026)

Commissioning and implementing a Quality Assurance program for dedicated radiation oncology MRI scanners
by: Eric Poulin, et al.
Published: (2024)

MORPHEUS: Modeling Role from Personalized Dialogue History by Exploring and Utilizing Latent Space
by: Tang, Yihong, et al.
Published: (2024)

Very early and early nutrition in children with pancreatitis—A randomised trial
by: Jan S. Bukowski, et al.
Published: (2024)

BUPD: A Bayesian under-parameterized basket design with the unit information prior in oncology trials
by: Kitabayashi, Ryo, et al.
Published: (2024)

Sample size reassessment in Bayesian hybrid clinical trials
by: Ratta, Marco, et al.
Published: (2025)

Confidence intervals for adaptive trial designs I: A methodological review
by: Robertson, David S., et al.
Published: (2024)

Platform trials: key features, when to use them and methodological challenges
by: Robert Mahar, et al.
Published: (2025)

Adverse immunostimulation in early phase clinical trials: Key findings and recommendations based on the investigator's clinical experience
by: Juliette A. van den Noort, et al.
Published: (2025)

The utility of recruitment incentives in early Alzheimer's disease trials
by: Marina Ritchie, et al.
Published: (2024)

Health equity in clinical trials for regional, rural and First nations communities: Need for networked clinical trial system, through a values and purpose‐aligned system culture
by: Sabe Sabesan, et al.
Published: (2024)

Generating real‐world evidence in early Alzheimer's disease: Considerations for applying the target trial emulation framework to study the safety of anti‐amyloid therapies
by: Xiaojuan Li, et al.
Published: (2025)

Augmented two-stage estimation for treatment crossover in oncology trials: Leveraging external data for improved precision
by: Campbell, Harlan, et al.
Published: (2024)

Telehealth vs face‐to‐face consultations in a urological oncology clinic: a randomised controlled trial
by: David Armany, et al.
Published: (2024)